JP2010512795A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010512795A5 JP2010512795A5 JP2009543078A JP2009543078A JP2010512795A5 JP 2010512795 A5 JP2010512795 A5 JP 2010512795A5 JP 2009543078 A JP2009543078 A JP 2009543078A JP 2009543078 A JP2009543078 A JP 2009543078A JP 2010512795 A5 JP2010512795 A5 JP 2010512795A5
- Authority
- JP
- Japan
- Prior art keywords
- lipase
- seq
- amylase
- protease
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000004367 Lipase Substances 0.000 claims 11
- 229940040461 Lipase Drugs 0.000 claims 11
- 102000004882 lipase Human genes 0.000 claims 11
- 235000019421 lipase Nutrition 0.000 claims 11
- 108090001060 lipase Proteins 0.000 claims 11
- 239000004382 Amylase Substances 0.000 claims 10
- 102000013142 Amylases Human genes 0.000 claims 10
- 108010065511 Amylases Proteins 0.000 claims 10
- 102000033147 ERVK-25 Human genes 0.000 claims 10
- 108091005771 Peptidases Proteins 0.000 claims 10
- 239000004365 Protease Substances 0.000 claims 10
- 235000019418 amylase Nutrition 0.000 claims 10
- 150000001413 amino acids Chemical class 0.000 claims 9
- 239000000203 mixture Substances 0.000 claims 6
- 102200048594 CD59 N33Q Human genes 0.000 claims 3
- 206010012601 Diabetes mellitus Diseases 0.000 claims 2
- 238000006467 substitution reaction Methods 0.000 claims 2
- 208000005407 Digestive System Disease Diseases 0.000 claims 1
- 102200012371 PRDM12 D31Y Human genes 0.000 claims 1
- 206010033628 Pancreatic insufficiency Diseases 0.000 claims 1
- 206010033645 Pancreatitis Diseases 0.000 claims 1
- 201000003883 cystic fibrosis Diseases 0.000 claims 1
- 230000001079 digestive Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 235000019626 lipase activity Nutrition 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000546 pharmaceutic aid Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Claims (9)
- 医療用リパーゼであって、
(a)配列番号:2のアミノ酸1〜269の配列に対して少なくとも50%の同一性を有し;
(b)リパーゼ活性を有し;そして
(c)配列番号:2のアミノ酸1〜269の配列に比べて、置換N33Q、T231R、N233R及びD254Sを含み、そして配列番号:2のN33Q+T231R+N233Rである参照リパーゼに比べて改良された消化性能を有する;
ことを特徴とするリパーゼ。 - 配列番号:2のアミノ酸1〜269の配列に対して置換:N33Q+G91T+K98I+T114I+G163K+T231R+N233R+D254Sを含む、請求項1に記載のリパーゼ。
- プロテアーゼ及び/又はアミラーゼとの組み合わせにおける、請求項1又は2に記載のリパーゼ。
- 請求項3に記載のプロテアーゼ及び/又はアミラーゼとの組み合わせにおけるリパーゼにおいて、
(i)当該プロテアーゼが、
a)配列番号:3のアミノ酸1〜274の配列を有するプロテアーゼ;
b)配列番号:4のアミノ酸1〜188の配列を有するプロテアーゼ;及び
c)配列番号:5のアミノ酸1〜188の配列を有するプロテアーゼ、
から成る群から選択されるプロテアーゼに対して少なくとも70%の同一性を有し;
(ii)前記アミラーゼが、
a)配列番号:6のアミノ酸1〜481の配列を有するアミラーゼ;
b)配列番号:7のアミノ酸1〜481の配列を有するアミラーゼ;
c)配列番号:8のアミノ酸1〜483の配列を有するアミラーゼ、
から成る群から選択されるアミラーゼに対して少なくとも70%の同一性を有する、
ことを特徴とする請求項3に記載のリパーゼ。 - 少なくとも1種の医薬として許容される賦形剤と共に、請求項1又は2に記載のリパーゼ又はリパーゼ混合物を含んで成る医薬組成物。
- プロテアーゼ及び/又はアミラーゼを更に含んで成る、請求項5に記載の組成物。
- 前記プロテアーゼ及び/又はアミラーゼが請求項4に記載したとおりでる、請求項6に記載の組成物。
- 消化系疾患、膵臓外分泌不全、膵炎、嚢胞性繊維症、I型糖尿病及び/又はII型糖尿病の治療のための医薬の製造における、請求項1又は2に記載のリパーゼ又はリパーゼ混合物の使用。
- アミラーゼ及び/又はプロテアーゼの使用をさらに含む、請求項8に記載の使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87119606P | 2006-12-21 | 2006-12-21 | |
US60/871,196 | 2006-12-21 | ||
PCT/US2007/087168 WO2008079685A2 (en) | 2006-12-21 | 2007-12-12 | Lipase variants for pharmaceutical use |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2010512795A JP2010512795A (ja) | 2010-04-30 |
JP2010512795A5 true JP2010512795A5 (ja) | 2011-02-03 |
JP5406040B2 JP5406040B2 (ja) | 2014-02-05 |
Family
ID=38043020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009543078A Active JP5406040B2 (ja) | 2006-12-21 | 2007-12-12 | 医薬使用のためのリパーゼ変異体 |
Country Status (16)
Country | Link |
---|---|
US (3) | US8273348B2 (ja) |
EP (6) | EP2099907A2 (ja) |
JP (1) | JP5406040B2 (ja) |
KR (1) | KR20090101930A (ja) |
CN (2) | CN105112386A (ja) |
AR (1) | AR064494A1 (ja) |
AU (1) | AU2007337150A1 (ja) |
BR (1) | BRPI0721103A2 (ja) |
CA (3) | CA2670643C (ja) |
IL (1) | IL198893A0 (ja) |
MX (1) | MX2009006597A (ja) |
NO (1) | NO20092729L (ja) |
RU (1) | RU2009128067A (ja) |
TW (1) | TW200829698A (ja) |
WO (1) | WO2008079685A2 (ja) |
ZA (1) | ZA200903598B (ja) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2005227090B2 (en) | 2004-03-22 | 2010-12-09 | Abbott Laboratories Gmbh | Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants |
US20070148151A1 (en) | 2005-07-29 | 2007-06-28 | Martin Frink | Processes for the manufacture and use of pancreatin |
US9198871B2 (en) | 2005-08-15 | 2015-12-01 | Abbott Products Gmbh | Delayed release pancreatin compositions |
US11266607B2 (en) | 2005-08-15 | 2022-03-08 | AbbVie Pharmaceuticals GmbH | Process for the manufacture and use of pancreatin micropellet cores |
US10072256B2 (en) | 2006-05-22 | 2018-09-11 | Abbott Products Gmbh | Process for separating and determining the viral load in a pancreatin sample |
US8273348B2 (en) * | 2006-12-21 | 2012-09-25 | Novozymes A/S | Lipase variants for pharmaceutical use |
AU2009218457B2 (en) | 2008-02-29 | 2013-10-24 | Dsm Ip Assets B.V. | Lipases with high specificity towards short chain fatty acids and uses thereof |
JP2011513539A (ja) * | 2008-02-29 | 2011-04-28 | ザ プロクター アンド ギャンブル カンパニー | リパーゼを含む洗剤組成物 |
MX337307B (es) * | 2008-02-29 | 2016-02-25 | Novozymes As | Variante de enzima lipolitica con estabilidad mejorada y polinucleotidos que codifican para la misma. |
EP2734633B1 (en) | 2011-07-22 | 2019-05-01 | Novozymes North America, Inc. | Processes for pretreating cellulosic material and improving hydrolysis thereof |
US8268305B1 (en) | 2011-09-23 | 2012-09-18 | Bio-Cat, Inc. | Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase |
CN110777016A (zh) * | 2011-12-29 | 2020-02-11 | 诺维信公司 | 具有脂肪酶变体的洗涤剂组合物 |
WO2013113622A1 (en) * | 2012-02-03 | 2013-08-08 | Novozymes A/S | Lipase variants and polynucleotides encoding same |
WO2013149858A1 (en) | 2012-04-02 | 2013-10-10 | Novozymes A/S | Lipase variants and polynucleotides encoding same |
KR20150067336A (ko) * | 2012-10-12 | 2015-06-17 | 다니스코 유에스 인크. | 지방분해 효소 변이체를 포함하는 조성물 및 방법 |
RU2020101263A (ru) * | 2013-05-14 | 2020-02-17 | Новозимс А/С | Моющие композиции |
MX2020001159A (es) * | 2013-07-19 | 2021-07-07 | Danisco Us Inc | Composiciones y metodos que comprenden una variante de enzima lipolitica. |
US10287562B2 (en) * | 2014-11-20 | 2019-05-14 | Novoszymes A/S | Alicyclobacillus variants and polynucleotides encoding same |
EP3227442B1 (en) * | 2014-12-05 | 2022-02-16 | Novozymes A/S | Lipase variants and polynucleotides encoding same |
CN107002053B (zh) | 2014-12-09 | 2021-07-27 | 诺维信公司 | 脂肪酶变体以及编码它们的多核苷酸 |
EP3280818A2 (en) | 2015-04-07 | 2018-02-14 | Novozymes A/S | Methods for selecting enzymes having lipase activity |
WO2017005640A1 (en) * | 2015-07-03 | 2017-01-12 | Novozymes A/S | Detergent compositions with improved stability in the presence of sulfites |
JP7081767B2 (ja) * | 2017-01-30 | 2022-06-07 | 学校法人日本医科大学 | アデノ随伴ウイルス(aav)キャプシドタンパク質の変異体 |
MX2020003779A (es) * | 2017-09-27 | 2020-08-03 | Procter & Gamble | Composiciones detergentes que comprenden lipasas. |
CN111356762A (zh) * | 2017-09-27 | 2020-06-30 | 诺维信公司 | 脂肪酶变体和包含此类脂肪酶变体的微囊组合物 |
EP3749760A1 (en) * | 2018-02-08 | 2020-12-16 | Novozymes A/S | Lipase variants and compositions thereof |
CN111334369B (zh) * | 2020-03-11 | 2022-10-21 | 陕西科技大学 | 一种酶法制备卵磷脂型pufa的方法 |
WO2022090361A2 (en) * | 2020-10-29 | 2022-05-05 | Novozymes A/S | Lipase variants and compositions comprising such lipase variants |
CN113846074B (zh) * | 2021-10-20 | 2022-10-21 | 南京林业大学 | 一种疏棉状嗜热丝孢菌脂肪酶突变体g91c及其应用 |
WO2023225459A2 (en) | 2022-05-14 | 2023-11-23 | Novozymes A/S | Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections |
Family Cites Families (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK173590D0 (da) | 1990-06-06 | 1990-07-19 | Novo Nordisk As | Rekombinante terapeutiske lipaser |
CA2092615A1 (en) | 1990-09-13 | 1992-03-14 | Allan Svendsen | Lipase variants |
DK46693D0 (ja) | 1993-04-23 | 1993-04-23 | Novo Nordisk As | |
US5869438A (en) | 1990-09-13 | 1999-02-09 | Novo Nordisk A/S | Lipase variants |
WO1992010755A1 (en) | 1990-12-05 | 1992-06-25 | Novo Nordisk A/S | Proteins with changed epitopes and methods for the production thereof |
WO1992019726A1 (en) | 1991-05-01 | 1992-11-12 | Novo Nordisk A/S | Stabilized enzymes |
DK39693D0 (da) | 1993-04-02 | 1993-04-02 | Novo Nordisk As | Enzym |
JPH09503130A (ja) | 1993-10-04 | 1997-03-31 | ノボ ノルディスク アクティーゼルスカブ | 修飾酵素を含んで成る酵素調製品 |
BR9506861A (pt) | 1994-02-22 | 1997-09-23 | Novo Nordisk As | Processo para preparar e produzir uma variante de uma enzima lipolítica originária variante de enzima liplítica construção de dna vetor célula hospedeira aditivo detergente e composição detergente |
WO1996016177A1 (en) | 1994-11-24 | 1996-05-30 | Novo Nordisk A/S | A process for producing polypeptides with reduced allergenicity |
EP0796324A1 (en) | 1994-12-07 | 1997-09-24 | Novo Nordisk A/S | Polypeptide with reduced allergenicity |
CA2209617C (en) | 1995-01-26 | 2002-05-28 | Novo Nordisk A/S | Animal feed additives comprising xylanase |
US6495357B1 (en) * | 1995-07-14 | 2002-12-17 | Novozyme A/S | Lipolytic enzymes |
WO1997004078A1 (en) | 1995-07-14 | 1997-02-06 | Novo Nordisk A/S | A modified enzyme with lipolytic activity |
DE69632538T2 (de) | 1995-08-11 | 2005-05-19 | Novozymes A/S | Neuartige lipolytische enzyme |
EP0954572A1 (en) | 1997-01-10 | 1999-11-10 | Novo Nordisk A/S | Enzyme coupled with polymeric molecules for skin care |
AU740207B2 (en) | 1997-02-06 | 2001-11-01 | Novozymes A/S | Polypeptide-polymer conjugates having added and/or removed attachment groups |
AU751880B2 (en) | 1997-06-25 | 2002-08-29 | Novozymes A/S | A modified polypeptide |
ATE328070T1 (de) * | 1998-02-17 | 2006-06-15 | Novozymes As | Lipasevariante |
AU3247699A (en) | 1998-02-17 | 1999-09-06 | Novo Nordisk A/S | Lipase variant |
WO2000022103A1 (en) | 1998-10-13 | 2000-04-20 | Novozymes A/S | A modified polypeptide with reduced immune response |
DE69916306T2 (de) | 1998-10-30 | 2005-05-04 | Novozymes A/S | Niedrigallergene proteinvarianten |
WO2000026354A1 (en) * | 1998-10-30 | 2000-05-11 | Novozymes A/S | Glycosylated proteins having reduced allergenicity |
US7312062B2 (en) * | 1998-11-27 | 2007-12-25 | Novozymes A/S | Lipolytic enzyme variants |
DK1131416T3 (da) | 1998-11-27 | 2009-10-26 | Novozymes As | Lipolytiske enzymvarianter |
CN1221284C (zh) | 1999-03-17 | 2005-10-05 | 索尔瓦药物有限公司 | 治疗糖尿病的药物 |
AU3420100A (en) * | 1999-03-31 | 2000-10-23 | Novozymes A/S | Lipase variant |
CA2366843A1 (en) * | 1999-03-31 | 2000-10-12 | Jesper Vind | Lipase variant |
ATE311762T1 (de) | 2000-02-08 | 2005-12-15 | Dsm Ip Assets Bv | Verwendung von säurestabilen subtilisinproteasen in tierfutter |
US20020192792A1 (en) | 2000-04-28 | 2002-12-19 | Palle Schneider | Laccase mutants |
JP2004522435A (ja) * | 2001-01-10 | 2004-07-29 | ノボザイムス アクティーゼルスカブ | 脂肪分解酵素変異体 |
AR032392A1 (es) * | 2001-01-19 | 2003-11-05 | Solvay Pharm Gmbh | Mezcla de enzimas, preparado farmaceutico y utilizacion de dicho preparado. |
DE60233782D1 (de) | 2001-02-07 | 2009-11-05 | Novozymes As | Lipasevarianten |
CA2467415C (en) * | 2002-01-16 | 2014-03-11 | Novozymes A/S | Lipolytic enzyme variants and method for their production |
US20060234340A1 (en) | 2003-02-06 | 2006-10-19 | Novozymes A/S | Human heavy chain antibody expression in flamentous fungi |
EP2270139B1 (en) | 2003-05-09 | 2016-07-27 | Novozymes A/S | Variant lipolytic enzymes |
WO2004111224A1 (en) | 2003-06-19 | 2004-12-23 | Novozymes A/S | Improved proteases and methods for producing them |
WO2004111216A2 (en) | 2003-06-19 | 2004-12-23 | Novozymes A/S | Phospholipase variants |
CA2553731A1 (en) | 2004-01-21 | 2005-08-04 | Novozymes A/S | Production of a monoclonal antibody in a heterokaryon fungus or in a fungal host cell |
AU2005227090B2 (en) | 2004-03-22 | 2010-12-09 | Abbott Laboratories Gmbh | Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants |
UA91521C2 (ru) | 2004-10-14 | 2010-08-10 | Элтус Фармасьютикалз Инк. | Композиции, содержащие липазу, протеазу и амилазу, предназначенные для лечения недостаточности поджелудочной железы |
EP1851311A2 (en) | 2005-02-10 | 2007-11-07 | Novozymes A/S | Enzymatic enantioselective ester or amide hydrolysis or synthesis |
CN101208429A (zh) * | 2005-06-24 | 2008-06-25 | 诺维信公司 | 用于药物用途的脂肪酶 |
BRPI0611936A2 (pt) | 2005-06-24 | 2011-02-22 | Solvay Pharm Gmbh | protease, uso de uma protease, composição farmacêutica, e, método para o tratamento de doença |
BRPI0611932A2 (pt) | 2005-06-24 | 2011-01-04 | Novozymes As | amilase, uso da mesma, composição farmacêutica, e, método para o tratamento de uma doença |
WO2007080197A2 (en) * | 2006-01-16 | 2007-07-19 | Novozymes A/S | Immobilised enzymes |
AR059154A1 (es) * | 2006-01-23 | 2008-03-12 | Procter & Gamble | Una composicion que comprende una lipasa y un catalizador de blanqueador |
EP1979477B1 (en) * | 2006-01-23 | 2017-04-19 | Novozymes A/S | Lipase variants |
US8273348B2 (en) * | 2006-12-21 | 2012-09-25 | Novozymes A/S | Lipase variants for pharmaceutical use |
-
2007
- 2007-12-12 US US12/519,868 patent/US8273348B2/en active Active
- 2007-12-12 EP EP07869130A patent/EP2099907A2/en not_active Withdrawn
- 2007-12-12 MX MX2009006597A patent/MX2009006597A/es not_active Application Discontinuation
- 2007-12-12 RU RU2009128067/10A patent/RU2009128067A/ru not_active Application Discontinuation
- 2007-12-12 CN CN201510504893.8A patent/CN105112386A/zh active Pending
- 2007-12-12 EP EP10172609.9A patent/EP2261328B1/en active Active
- 2007-12-12 EP EP12155315A patent/EP2455460A3/en not_active Withdrawn
- 2007-12-12 AU AU2007337150A patent/AU2007337150A1/en not_active Abandoned
- 2007-12-12 EP EP12155319.2A patent/EP2455462B1/en active Active
- 2007-12-12 WO PCT/US2007/087168 patent/WO2008079685A2/en active Application Filing
- 2007-12-12 EP EP12155294.7A patent/EP2455459B1/en active Active
- 2007-12-12 JP JP2009543078A patent/JP5406040B2/ja active Active
- 2007-12-12 CA CA2670643A patent/CA2670643C/en active Active
- 2007-12-12 CN CN200780051638.6A patent/CN101743308B/zh active Active
- 2007-12-12 CA CA3081308A patent/CA3081308C/en active Active
- 2007-12-12 BR BRPI0721103-1A patent/BRPI0721103A2/pt not_active IP Right Cessation
- 2007-12-12 CA CA2961041A patent/CA2961041C/en active Active
- 2007-12-12 KR KR1020097014850A patent/KR20090101930A/ko not_active Application Discontinuation
- 2007-12-12 EP EP12155317.6A patent/EP2455461B1/en active Active
- 2007-12-18 TW TW096148377A patent/TW200829698A/zh unknown
- 2007-12-21 AR ARP070105859A patent/AR064494A1/es not_active Application Discontinuation
-
2009
- 2009-05-21 IL IL198893A patent/IL198893A0/en unknown
- 2009-05-25 ZA ZA200903598A patent/ZA200903598B/xx unknown
- 2009-07-20 NO NO20092729A patent/NO20092729L/no not_active Application Discontinuation
-
2012
- 2012-08-16 US US13/587,043 patent/US9029115B2/en active Active
-
2015
- 2015-04-06 US US14/679,563 patent/US9539311B2/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2010512795A5 (ja) | ||
RU2007149045A (ru) | Липазы для фармацевтического применения | |
RU2008102650A (ru) | Амилазы для фармацевтического применения | |
RU2008102738A (ru) | Протеазы для фармацевтического применения | |
RU2006145899A (ru) | Ферменты для фармацевтического применения | |
JP2016505539A5 (ja) | ||
HRP20190918T1 (hr) | Ciljani terapeutski fuzijski proteini lizosomskog enzima i njihova upotreba | |
JP2008521906A5 (ja) | ||
WO2015038892A1 (en) | Polynucleotide compositions containing amino acids | |
NO20092729L (no) | Lipasevarianter for farmasoytisk anvendelse | |
JP2011528895A5 (ja) | ||
JP2016530294A (ja) | キメラポリヌクレオチド | |
RU2001126526A (ru) | Лекарственное средство, предназначенное для лечения диабета | |
JP2008536483A5 (ja) | ||
JP2012115277A5 (ja) | ||
RU2010127329A (ru) | Варианты протеаз для фармацевтического применения | |
JP2014513952A5 (ja) | ||
JP2008541776A5 (ja) | ||
JP2012521366A5 (ja) | ||
JP2008512399A5 (ja) | ||
WO2010086867A3 (en) | Peptides, pharmaceutical compositions comprising same and uses thereof | |
MX2021012784A (es) | Un nuevo tipo de composicion enzimatica. | |
Xu et al. | Breaking Genetic Shackles: The Advance of Base Editing in Genetic Disorder Treatment | |
WO2015009596A8 (en) | Methods and oral formulations for enzyme replacement therapy of human lysosomal and metabolic diseases | |
JP2009500314A5 (ja) |